Finance

Lists
EVKIY:OTCMKTS
Evonik Industries Unsponsored ADR Representing 0.5 Ord Shs
$10.08
-4.57%
(-0.48) 1D
Aug 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVKIY...
Open
$10.06
High
$10.16
Low
$9.83
Mkt. cap
8.39B
Avg. vol.
30.36K
Volume
1.81K
52-wk high
$10.66
52-wk low
$7.24
Beta
0.60
Shares outstanding
932.00M
No. of employees
30K
Open
$10.06
High
$10.16
Low
$9.83
Mkt. cap
8.39B
Avg. vol.
30.36K
Volume
1.81K
52-wk high
$10.66
52-wk low
$7.24
Beta
0.60
Shares outstanding
932.00M
No. of employees
30K
Profile
Evonik Industries AG is a publicly listed German chemicals company headquartered in Essen, North Rhine-Westphalia, Germany. It is the second-largest chemicals company in Germany, and one of the largest specialty chemicals companies in the world. It is predominantly owned by the RAG Foundation and was founded on 12 September 2007 as a result of restructuring of the mining and technology group RAG AG. Evonik Industries united the business areas of chemicals, energy and real estate of RAG, while mining operations continue to be carried out by RAG. Since then, the energy and real estate business areas have been divested, with no share being held in the former and a minority share still being held in the latter. Its specialty chemicals business generates around 80% of sales in areas where it holds leading market positions. Evonik Industries employs about 31,000 people and carries out activities in more than 100 countries. The operating activities are organized into six business units that are a part of the chemicals business area. Up until 2025 Evonik was a main sponsor of the German football club Borussia Dortmund and now is Champion Partner. Wikipedia
About Evonik Industries Unsponsored ADR Representing 0.5 Ord Shs
CEOChristian Kullmann
Employees30.4K
FoundedSep 12, 2007
Headquarters-
SectorSpeciality chemicals
Websiteevonik.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.39B
3.40B
3.43B
3.89B
Cost of goods sold
2.78B
2.50B
2.56B
2.93B
Cost of revenue
2.78B
2.50B
2.56B
2.93B
Research and development expenses
104.00M
104.00M
94.00M
96.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
531.00M
537.00M
533.00M
590.00M
Operating expense
642.00M
505.00M
636.00M
801.00M
Total operating expenses
3.42B
3.00B
3.20B
3.73B
Operating income
-26.00M
400.00M
228.00M
161.00M
Other non operating income
-3.00M
5.00M
-5.00M
-51.00M
EBT including unusual items
-77.00M
38.00M
183.00M
122.00M
EBT excluding unusual items
-77.00M
358.00M
183.00M
122.00M
Income tax expense
25.00M
18.00M
54.00M
37.00M
Effective tax rate
-32.47%
47.37%
29.51%
30.33%
Other operating expenses
7.00M
-136.00M
9.00M
115.00M
Net income
-106.00M
18.00M
125.00M
84.00M
Net profit margin
-3.13%
0.53%
3.65%
2.16%
Earnings per share
0.27
0.15
0.34
0.65
Interest and investment income
7.00M
40.00M
10.00M
10.00M
Interest expense
-56.00M
-54.00M
-51.00M
-
Net interest expenses
-49.00M
-14.00M
-41.00M
10.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
402.00M
450.00M
467.00M
537.00M
Gain or loss from assets sale
5.00M
-13.00M
-2.00M
7.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps